insights_auto
Per què 2269 ha baixat 3,10%?
Aprofundeix méschevron_right
2269:HKG
WuXi Biologics (Cayman) Inc
49,66 HK$
arrow_downward
-3,10%(-1,59) 1d
14 d’oct., 15:59:35 GMT+8 · HKD
search
Tots els símbols
| Símbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadístiques principals per a 2269...
Obre
50,60 HK$
Alt
51,35 HK$
Baix
49,40 HK$
Capitalització borsària
204,44 kM
Volum mitjà
30,95 M
Volum
22,50 M
Ràtio preu-benefici
35,52
Alt 52 setmanes
58,00 HK$
Baix 52 setmanes
28,48 HK$
BPA
1,40 HK$
Accions en circulació
1225,23 M
Nombre d'empleats
15 k
Obre
50,60 HK$
Alt
51,35 HK$
Baix
49,40 HK$
Capitalització borsària
204,44 kM
Volum mitjà
30,95 M
Volum
22,50 M
Ràtio preu-benefici
35,52
Alt 52 setmanes
58,00 HK$
Baix 52 setmanes
28,48 HK$
BPA
1,40 HK$
Accions en circulació
1225,23 M
Nombre d'empleats
15 k
Notícies
De fonts web i partners de notícies
Perfil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Sobre WuXi Biologics (Cayman) Inc
Conseller delegatZhisheng Chen
Empleats14,7 k
Fundació2010
Seu principal-
Sector-
Lloc webwuxibiologics.com